Drug interaction potentials among different brands of grapefruit juice

被引:8
|
作者
Uesawa, Y. [1 ]
Mohri, K. [1 ]
机构
[1] Meiji Pharmaceut Univ, Dept Pharmaceut, Clin Pharmaceut Lab, Tokyo 2048588, Japan
来源
PHARMAZIE | 2008年 / 63卷 / 02期
关键词
D O I
10.1691/ph.2008.7219
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The discrepancy of drug-interaction potential among different brands of grapefruit juice was estimated based on inhibition of CYP3A activity caused by furanocoumarin derivatives in the grapefruit juice. Heat treatment of the grapefruit juice at 95 degrees C for 1 h was utilized to degrade the furanocoumarins. Initial velocity of testosterone 6 beta-oxidation using human liver microsomes was determined as an indicator of the CYP3A activities. Changes in the velocities of the reaction mixture were observed when 10% of each brand of untreated grapefruit juice or heat-treated grapefruit juice was added. The differences in the velocities between untreated and heat-treated grapefruit juice were defined as the potentials of furanocoumarin-caused CYP3A-inhibitions.
引用
收藏
页码:144 / 146
页数:3
相关论文
共 50 条
  • [41] Interaction between grapefruit juice and diazepam in humans
    Özdemir M.
    Aktan Y.
    Boydaǧ B.S.
    Cingi M.I.
    Musmul A.
    European Journal of Drug Metabolism and Pharmacokinetics, 1998, 23 (1) : 55 - 59
  • [42] Interaction between grapefruit juice and praziquantel in humans
    Castro, N
    Jung, H
    Medina, R
    González-Esquivel, D
    Lopez, M
    Sotelo, J
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (05) : 1614 - 1616
  • [43] A furanocoumarin-free grapefruit juice establishes furanocoumarins as the mediators of the grapefruit juice-felodipine interaction
    Paine, Mary F.
    Widmer, Wilbur W.
    Hart, Heather L.
    Pusek, Susan N.
    Beavers, Kimberly L.
    Criss, Anne B.
    Brown, Sherri S.
    Thomas, Brian F.
    Watkins, Paul B.
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2006, 83 (05): : 1097 - 1105
  • [44] Whither grapefruit and drug interaction?
    Girennavar, Basavaraj
    Poulose, Shibu M.
    Brodbelt, Jennifer S.
    Jayaprakasha, Guddadarangawanahally K.
    Bhat, Narayan G.
    Patil, Bhimanagouda S.
    POTENTIAL HEALTH BENEFITS OF CITRUS, 2006, 936 : 219 - 234
  • [45] Whither grapefruit drug interaction?
    Girennavar, BR
    Jayaprakasha, GK
    Brodbeft, JS
    Bhat, NG
    Patil, BS
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U73 - U73
  • [46] Prediction of the extent and variation of grapefruit juice-drug interactions from the pharmacokinetic profile in the absence of grapefruit juice
    Kogure, Natsuki
    Akiyoshi, Takeshi
    Imaoka, Ayuko
    Ohtani, Hisakazu
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2014, 35 (07) : 373 - 381
  • [47] Prioritizing Pharmacokinetic Drug Interaction Precipitants in Natural Products: Application to OATP Inhibitors in Grapefruit Juice
    Johnson, Emily J.
    Won, Christina S.
    Koeck, Kathleen
    Paine, Mary F.
    FASEB JOURNAL, 2017, 31
  • [48] GRAPEFRUIT JUICE-FELODIPINE INTERACTION - REPRODUCIBILITY AND CHARACTERIZATION WITH THE EXTENDED-RELEASE DRUG FORMULATION
    BAILEY, DG
    ARNOLD, JMO
    BEND, JR
    TRAN, LT
    SPENCE, JD
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 40 (02) : 135 - 140
  • [49] Prioritizing pharmacokinetic drug interaction precipitants in natural products: application to OATP inhibitors in grapefruit juice
    Johnson, Emily J.
    Won, Christina S.
    Kock, Kathleen
    Paine, Mary F.
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2017, 38 (03) : 251 - 259
  • [50] PHARMACOKINETIC INTERACTION BETWEEN LINEZOLID AND GRAPEFRUIT JUICE IN RATS
    Cuciureanu, Rodica
    Vlase, L.
    Muntean, Dana
    Cuciureanu, Magdalena
    FARMACIA, 2010, 58 (06) : 770 - 778